Role of Cochrane Reviews in informing US private payers’ policies

  title={Role of Cochrane Reviews in informing US private payers’ policies},
  author={Ambrish Singh and Salman Hussain and Abul Kalam Najmi},
  journal={Journal of Evidence‐Based Medicine},
  pages={293 - 331}
To assess the use of Cochrane Reviews to inform the medical policy documents of major US private payers. 

Consideration of sex and gender in Cochrane reviews of interventions for preventing healthcare-associated infections: a methodology study

Lack of attention to sex and gender reduces the quality of Cochrane reviews, and their applicability for all people: women and men, boys and girls, and people of diverse gender identities.

Imatinib and Patient-Related Outcomes in Chronic Myeloid Leukemia: A Single Centric Experience

The CML patients with P210-kD protein were at higher risk while P190 kD and coexistence were at a lower risk of progression to blastic and further to accelerated phase based on EUTOS score, and it is advisable to identify the BCR-ABL fusion transcript in CML with Imatinib treatment.



New evidence pyramid

Another way of looking at the evidence-based medicine pyramid is suggested and it is explained how systematic reviews and meta-analyses are tools for consuming evidence—that is, appraising, synthesising and applying evidence.

Evidence based medicine: what it is and what it isn't

As evidence based medicine continues to evolve and adapt, now is a useful time to refine the discussion of what it is andWhat it is not.

Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review

Industry supported reviews of drugs should be read with caution as they were less transparent, had few reservations about methodological limitations of the included trials, and had more favourable conclusions than the corresponding Cochrane reviews.

Quality of Cochrane reviews: assessment of sample from 1998

Too often, reviewers' conclusions over-rated the benefits of new interventions and readers of Cochrane reviews should remain cautious, especially regarding conclusions that favour new interventions.

Biologics for rheumatoid arthritis: an overview of Cochrane reviews.

Anakinra seemed less efficacious than etanercept, adalimumab and rituximab and etanerscept seemed to cause fewer withdrawals due to adverse events than ad alimumab, anakinra and infliximab, according to indirect comparisons.

Systematic reviews and meta-analyses.

  • D. Menzies
  • Medicine
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
  • 2011
Systematic reviews can help identify research priorities as areas where knowledge is uncertain, and also those topics where little additional work is required, and can have a substantial impact on practice and policy.

Can patients assess the quality of health care?

  • A. Coulter
  • Medicine
    BMJ : British Medical Journal
  • 2006
Patients' surveys should ask about real experiences of medical care, according to the Royal College of Surgeons.

dence based medicine : what it is and what it isn ' t

  • BMJ
  • 1996